GCP
CDMO

GSA Capital Partners’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

GSA Capital Partners’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-153,070
Closed -$1.74M – 2110
2024
Q3 		$1.74M Buy
153,070
+75,473
+97% +$757K 0.13% 171
2024
Q2 		$554K Sell
77,597
-15,098
-16% -$115K 0.04% 891
2024
Q1 		$621K Buy
92,695
+73,962
+395% +$509K 0.05% 756
2023
Q4 		$122K Sell
18,733
-21,285
-53% -$137K 0.01% 1383
2023
Q3 		$378K Buy
40,018
+26,985
+207% +$325K 0.03% 960
2023
Q2 		$182K Buy
+13,033
New +$222K 0.02% 1297
2023
Q1 		– Sell
-36,434
Closed -$502K – 2006
2022
Q4 		$502K Buy
36,434
+24,039
+194% +$368K 0.06% 598
2022
Q3 		$237K Sell
12,395
-61,229
-83% -$1.12M 0.03% 1094
2022
Q2 		$1.12M Buy
+73,624
New +$1.09M 0.17% 102
2021
Q3 		– Sell
-19,570
Closed -$502K – 1846
2021
Q2 		$502K Buy
+19,570
New +$418K 0.06% 619
2020
Q4 		– Sell
-42,391
Closed -$323K – 1674
2020
Q3 		$323K Buy
42,391
+13,782
+48% +$104K 0.05% 683
2020
Q2 		$188K Sell
28,609
-76,175
-73% -$425K 0.1% 369
2020
Q1 		$535K Buy
104,784
+62,911
+150% +$381K 0.13% 141
2019
Q4 		$321K Buy
+41,873
New +$244K 0.04% 973
2019
Q3 		– Sell
-33,584
Closed -$188K – 1769
2019
Q2 		$188K Sell
33,584
-39,383
-54% -$162K 0.02% 1255
2019
Q1 		$310K Buy
+72,967
New +$298K 0.03% 974
2018
Q4 		– Sell
-23,700
Closed -$163K – 1809
2018
Q3 		$163K Buy
+23,700
New +$141K 0.01% 1518

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

GSA Capital Partners's CDMO Position: Q4 2024 in Review

GSA Capital Partners sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2024, closing a stake of 153,070 shares — an estimated $1.74M sold.

GSA Capital Partners first reported a position in CDMO in Q3 2018 and held it in 17 quarters. The position peaked at $1.74M in Q3 2024. 195 funds tracked by Wall St. Rank hold CDMO as of Q4 2024.

  • GSA Capital Partners reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • GSA Capital Partners sold 153,070 Avid Bioservices, Inc. Common Stock shares in Q4 2024, an estimated $1.74M.
  • GSA Capital Partners first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2018 and held it in 17 quarters.
  • GSA Capital Partners's Avid Bioservices, Inc. Common Stock position peaked at $1.74M in Q3 2024.
  • 195 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2024.

Based on GSA Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.